India · Delayed Price · Currency is INR Neuland Laboratories Statistics
Total Valuation
NSE:NEULANDLAB has a market cap or net worth of INR 168.20 billion. The enterprise value is 167.38 billion.
| Market Cap | 168.20B |
| Enterprise Value | 167.38B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 12.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.19M |
Valuation Ratios
The trailing PE ratio is 95.49 and the forward PE ratio is 46.53.
| PE Ratio | 95.49 |
| Forward PE | 46.53 |
| PS Ratio | 12.65 |
| PB Ratio | 11.03 |
| P/TBV Ratio | 13.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 95.03 |
| EV / Sales | 12.58 |
| EV / EBITDA | 70.49 |
| EV / EBIT | 97.17 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | n/a |
| Interest Coverage | 22.36 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.04% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.41M |
| Profits Per Employee | 981,803 |
| Employee Count | 1,794 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:NEULANDLAB has paid 579.22 million in taxes.
| Income Tax | 579.22M |
| Effective Tax Rate | 24.75% |
Stock Price Statistics
The stock price has increased by +17.48% in the last 52 weeks. The beta is 0.03, so NSE:NEULANDLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +17.48% |
| 50-Day Moving Average | 12,850.12 |
| 200-Day Moving Average | 13,149.40 |
| Relative Strength Index (RSI) | 48.81 |
| Average Volume (20 Days) | 173,028 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEULANDLAB had revenue of INR 13.30 billion and earned 1.76 billion in profits. Earnings per share was 137.27.
| Revenue | 13.30B |
| Gross Profit | 6.40B |
| Operating Income | 1.72B |
| Pretax Income | 2.34B |
| Net Income | 1.76B |
| EBITDA | 2.33B |
| EBIT | 1.72B |
| Earnings Per Share (EPS) | 137.27 |
Balance Sheet
The company has 2.40 billion in cash and 1.57 billion in debt, giving a net cash position of 824.76 million.
| Cash & Cash Equivalents | 2.40B |
| Total Debt | 1.57B |
| Net Cash | 824.76M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 15.25B |
| Book Value Per Share | 1,188.48 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 48.09%, with operating and profit margins of 12.95% and 13.24%.
| Gross Margin | 48.09% |
| Operating Margin | 12.95% |
| Pretax Margin | 17.60% |
| Profit Margin | 13.24% |
| EBITDA Margin | 17.48% |
| EBIT Margin | 12.95% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 12.00 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -14.29% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 1.05% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |